More tools:Markets·Screener·Research·Chat

Cypherpunk Technologies Inc. Common Stock (CYPH) Financial Statements

Cypherpunk Technologies Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00DQ929Z3
XNAS · usd
2.63▲ 0.21 (8.68%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close2.42
Day's Range2.30 – 2.83
52-Week Range0.49 – 2.83
Volume17.7M
Avg Volume7.0M
Share Statistics
Shares Outstanding
Employees6
ExchangeXNAS
Listed2014-07-31
Share count as of August 10, 2026
Loading Income Statement…
Key questions about Cypherpunk Technologies Inc. Common Stock (CYPH)
What is Cypherpunk Technologies Inc. Common Stock's Market Cap?
Cypherpunk Technologies Inc. Common Stock's Market Cap is $283.4M, based on as-reported figures from SEC (XBRL) filings.
What is Cypherpunk Technologies Inc. Common Stock's Enterprise Value?
Cypherpunk Technologies Inc. Common Stock's Enterprise Value is $275.8M, based on as-reported figures from SEC (XBRL) filings.
What is Cypherpunk Technologies Inc. Common Stock's EV / EBITDA?
Cypherpunk Technologies Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cypherpunk Technologies Inc. Common Stock's Net Income (TTM)?
Cypherpunk Technologies Inc. Common Stock's Net Income (TTM) is -$877.0K, based on as-reported figures from SEC (XBRL) filings.
What is Cypherpunk Technologies Inc. Common Stock's EBITDA?
Cypherpunk Technologies Inc. Common Stock's EBITDA is -$17.8M, based on as-reported figures from SEC (XBRL) filings.
What is Cypherpunk Technologies Inc. Common Stock's Diluted EPS (TTM)?
Cypherpunk Technologies Inc. Common Stock's Diluted EPS (TTM) is -0.01, based on as-reported figures from SEC (XBRL) filings.
What is Cypherpunk Technologies Inc. Common Stock's Net Debt?
Cypherpunk Technologies Inc. Common Stock's Net Debt is -$7.6M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Revenues——
YoY growth+4.3%-17.2%——
Costs and expenses:
Cost of Goods and Services Sold——
Selling, general and administrative——
Research and development
Amortization of intangible assets——
Total costs and expenses——
% of revenue104.3%141.1%——
Operating loss
% of revenue-4.3%-41.1%——
Other income (expense), net:
Interest income
Interest expense
Fair value changes of derivative instruments, net——
Other income (expense), net——
Other expense, net——
Loss before income taxes and investment losses——
Income tax benefit
Net loss before investment losses——
Net loss
% of revenue-5.1%-44.2%——
Loss per share, basic—
Loss per share, diluted—